ICON Public (NASDAQ:ICLR) Updates FY 2025 Earnings Guidance

ICON Public (NASDAQ:ICLRGet Free Report) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 13.000-15.000 for the period, compared to the consensus earnings per share estimate of 14.930. The company issued revenue guidance of $8.1 billion-$8.7 billion, compared to the consensus revenue estimate of $8.5 billion. ICON Public also updated its FY 2024 guidance to 13.900-14.100 EPS.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on the company. JPMorgan Chase & Co. reduced their price objective on ICON Public from $375.00 to $280.00 and set an “overweight” rating for the company in a research report on Friday, October 25th. Truist Financial reaffirmed a “buy” rating and set a $284.00 target price (down previously from $295.00) on shares of ICON Public in a research note on Wednesday, December 18th. Baird R W cut ICON Public from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 24th. Royal Bank of Canada restated an “outperform” rating and set a $263.00 price objective on shares of ICON Public in a research note on Wednesday. Finally, TD Cowen reduced their price objective on shares of ICON Public from $369.00 to $285.00 and set a “buy” rating for the company in a report on Friday, October 25th. Four research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $287.00.

Get Our Latest Stock Report on ICLR

ICON Public Stock Performance

ICON Public stock opened at $199.47 on Thursday. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.34 and a quick ratio of 1.34. The company has a market cap of $16.46 billion, a P/E ratio of 22.24, a price-to-earnings-growth ratio of 1.59 and a beta of 1.20. ICON Public has a fifty-two week low of $183.38 and a fifty-two week high of $347.72. The firm’s 50 day simple moving average is $210.79 and its 200-day simple moving average is $270.01.

ICON Public (NASDAQ:ICLRGet Free Report) last announced its earnings results on Wednesday, October 23rd. The medical research company reported $3.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.72 by ($0.37). ICON Public had a net margin of 9.00% and a return on equity of 11.91%. The firm had revenue of $2.03 billion for the quarter, compared to analyst estimates of $2.13 billion. During the same period last year, the firm earned $3.10 earnings per share. ICON Public’s revenue for the quarter was down 1.2% compared to the same quarter last year. As a group, equities research analysts predict that ICON Public will post 13.41 EPS for the current year.

ICON Public Company Profile

(Get Free Report)

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.

Featured Articles

Earnings History and Estimates for ICON Public (NASDAQ:ICLR)

Receive News & Ratings for ICON Public Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICON Public and related companies with MarketBeat.com's FREE daily email newsletter.